Earlier antidepressants, like tricyclic antidepressants (TCAs) and MAO inhibitors (MAOI), were commonly used but are now rarely prescribed due to their adverse health effects [11]
[5] Newborns have the greatest NAD+ levels, which gradually decrease as they get older chronologically
Multiple pharmacokinetic studies have shown that TPGS modification can significantly improve AUC, half-life, and MRT of oral administration
Mild cognitive impairment (MCI), characterized by deficits beyond that anticipated for an individuals age and education, but without functional impairment, is often the earliest clinical stage of AD [4]
Most evidence for BPC-157s efficacy and safety comes from animal studies, with limited human clinical data available
Oral supplements offer convenient daily administration with various formulation options, though they typically show gradual absorption rates